Skip to main content
. Author manuscript; available in PMC: 2016 Aug 15.
Published in final edited form as: Bioorg Med Chem. 2014 Dec 20;23(16):5210–5217. doi: 10.1016/j.bmc.2014.12.020

Figure 2.

Figure 2

Validation sets including the FDA approved (light blue) and 1000 randomly selected molecules from the AldrichCPR drug-like compounds (dark blue) in relation to the TCAMS (red), OU (gold) and VU (green) βH inhibitors from the training set.